Latest Insider Transactions at Black Diamond Therapeutics, Inc. (BDTX)
This section provides a real-time view of insider transactions for Black Diamond Therapeutics, Inc. (BDTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Black Diamond Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Black Diamond Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2024
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
5,750
+8.32%
|
$11,500
$2.5 P/Share
|
|
Dec 13
2024
|
Shannon Campbell |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+33.67%
|
$9,000
$2.5 P/Share
|
|
Dec 13
2024
|
Prakash Raman |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+33.67%
|
$10,300
$2.5 P/Share
|
|
Sep 20
2024
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
3,007
+4.96%
|
$12,028
$4.78 P/Share
|
|
Sep 20
2024
|
Shannon Campbell |
BUY
Grant, award, or other acquisition
|
Direct |
2,354
+35.04%
|
$9,416
$4.78 P/Share
|
|
Sep 20
2024
|
Prakash Raman |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+35.04%
|
$10,776
$4.78 P/Share
|
|
Aug 28
2024
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
221,600
-5.61%
|
$1,329,600
$6.32 P/Share
|
|
Jun 21
2024
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
2,887
+5.02%
|
$11,548
$4.98 P/Share
|
|
Jun 21
2024
|
Shannon Campbell |
BUY
Grant, award, or other acquisition
|
Direct |
2,011
+50.0%
|
$8,044
$4.98 P/Share
|
|
Jun 21
2024
|
Prakash Raman |
BUY
Grant, award, or other acquisition
|
Direct |
2,301
+50.0%
|
$9,204
$4.98 P/Share
|
|
Mar 15
2024
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
3,166
+5.77%
|
$12,664
$4.54 P/Share
|
|
Mar 15
2024
|
Wendy L Dixon |
BUY
Grant, award, or other acquisition
|
Direct |
3,253
+7.88%
|
$13,012
$4.54 P/Share
|
|
Dec 15
2023
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
4,455
+8.41%
|
$8,910
$2.73 P/Share
|
|
Dec 15
2023
|
Wendy L Dixon |
BUY
Grant, award, or other acquisition
|
Direct |
4,043
+10.41%
|
$8,086
$2.73 P/Share
|
|
Oct 17
2023
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
400,000
+4.49%
|
$800,000
$2.34 P/Share
|
|
Sep 15
2023
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
3,299
+6.96%
|
$9,897
$3.6 P/Share
|
|
Sep 15
2023
|
Wendy L Dixon |
BUY
Grant, award, or other acquisition
|
Direct |
2,986
+8.85%
|
$8,958
$3.6 P/Share
|
|
Sep 15
2023
|
Mark A. Velleca PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+10.07%
|
$15,624
$3.6 P/Share
|
|
Jul 05
2023
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
935,850
+22.55%
|
$4,679,250
$5.0 P/Share
|
|
Jul 05
2023
|
Ali Behbahani |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+18.35%
|
$5,000,000
$5.0 P/Share
|
|
Jun 30
2023
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
1,000,000
+10.97%
|
$5,000,000
$5.0 P/Share
|
|
Jun 27
2023
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
1,740,000
+19.64%
|
$8,700,000
$5.49 P/Share
|
|
Jun 27
2023
|
David M. Epstein |
SELL
Open market or private sale
|
Direct |
25,000
-3.59%
|
$150,000
$6.7 P/Share
|
|
Jun 16
2023
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
5,655
+12.18%
|
$11,310
$2.1 P/Share
|
|
Jun 16
2023
|
Mark A. Velleca PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,929
+17.77%
|
$17,858
$2.1 P/Share
|
|
Jun 16
2023
|
Wendy L Dixon |
BUY
Grant, award, or other acquisition
|
Direct |
5,119
+15.56%
|
$10,238
$2.1 P/Share
|
|
Mar 16
2023
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
7,111
+16.84%
|
$7,111
$1.67 P/Share
|
|
Mar 16
2023
|
Mark A. Velleca PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,228
+25.74%
|
$11,228
$1.67 P/Share
|
|
Mar 16
2023
|
Wendy L Dixon |
BUY
Grant, award, or other acquisition
|
Direct |
6,437
+22.13%
|
$6,437
$1.67 P/Share
|
|
Feb 13
2023
|
Erika Jones |
BUY
Grant, award, or other acquisition
|
Direct |
5,075
+33.33%
|
-
|
|
Dec 22
2022
|
Fang Ni |
BUY
Open market or private purchase
|
Direct |
36,363
+22.48%
|
$36,363
$1.28 P/Share
|
|
Dec 21
2022
|
Fang Ni |
BUY
Open market or private purchase
|
Direct |
20,000
+18.34%
|
$20,000
$1.29 P/Share
|
|
Dec 16
2022
|
Robert Alexander Ingram |
BUY
Grant, award, or other acquisition
|
Direct |
9,375
+17.95%
|
$9,375
$1.5 P/Share
|
|
Dec 16
2022
|
Wendy L Dixon |
BUY
Grant, award, or other acquisition
|
Direct |
7,167
+30.65%
|
$7,167
$1.5 P/Share
|
|
Dec 16
2022
|
Mark A. Velleca PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,424
+28.48%
|
$8,424
$1.5 P/Share
|
|
Dec 16
2022
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
7,917
+22.04%
|
$7,917
$1.5 P/Share
|
|
Oct 31
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
99,801
+1.82%
|
$199,602
$2.25 P/Share
|
|
Oct 28
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
172,974
+3.17%
|
$345,948
$2.18 P/Share
|
|
Oct 27
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
191,678
+3.62%
|
$191,678
$1.87 P/Share
|
|
Oct 21
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
87,850
+1.76%
|
$87,850
$1.51 P/Share
|
|
Oct 20
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
53,734
+1.1%
|
$53,734
$1.42 P/Share
|
|
Oct 19
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
77,689
+1.6%
|
$77,689
$1.32 P/Share
|
|
Sep 16
2022
|
Wendy L Dixon |
BUY
Grant, award, or other acquisition
|
Direct |
4,103
+31.2%
|
$8,206
$2.62 P/Share
|
|
Sep 16
2022
|
Mark A. Velleca PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,294
+25.22%
|
$8,588
$2.62 P/Share
|
|
Sep 16
2022
|
Robert Alexander Ingram |
BUY
Grant, award, or other acquisition
|
Direct |
6,584
+16.43%
|
$13,168
$2.62 P/Share
|
|
Sep 16
2022
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
4,532
+18.41%
|
$9,064
$2.62 P/Share
|
|
Jun 29
2022
|
Fang Ni |
BUY
Open market or private purchase
|
Direct |
25,000
+26.59%
|
$50,000
$2.44 P/Share
|
|
Jun 17
2022
|
Robert Alexander Ingram |
BUY
Grant, award, or other acquisition
|
Direct |
8,498
+24.01%
|
$16,996
$2.03 P/Share
|
|
Jun 17
2022
|
Wendy L Dixon |
BUY
Grant, award, or other acquisition
|
Direct |
4,060
+50.0%
|
$8,120
$2.03 P/Share
|
|
Jun 17
2022
|
Mark A. Velleca PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,542
+39.64%
|
$11,084
$2.03 P/Share
|